EDAP

European ADRs Advance as Pharma Stocks See Mixed Fortunes

An image of a calculator, a smartphone and a chart on a clip board Credit: Shutterstock photo

American depository receipts of European stocks were 0.4% higher at 134.99 on the Bank of New York Mellon Europe ADR Index on Wednesday morning.

Gainers in Continental Europe were led by CGG ( CGG ), a manufacturer of geophysical equipment, 6% higher, followed by Edap ( EDAP ), a French medical devices developer, up by 4.6% and Deutsche Bank - Global Registered Shares ( DB ), up by 2%. Grifols ( GRFS ), a Spanish healthcare company, was 1.8% higher.

In the UK, Akari Therapeutics ( AKTX ), a development-stage biopharmaceutical company, was 4.2% higher, followed by Motif Bio (MTFB), a clinical-stage biopharmaceutical company, up by 4% and Amec Foster Wheeler (AMFW), a global engineering conglomerate, 3.2% higher. Shire (SHPG), biopharmaceutical company, was up by 1.8%.

Decliners in Continental Europe were led by Trivago (TRVG), an online hotel search platform, down by 24.3%, followed by Oasmia Pharmaceutical (OASM), a Sweden-based pharmaceutical company, 3% lower and Forward Pharma (FWP), a Danish biopharmaceutical company, down by 1.1%. Telecom Italia Savings (TI.A), an Italian telecommunications company, was 0.8% lower.

And, in the UK, Randgold Resources (GOLD), a gold mining company, was 0.8% lower, followed by RELX (RELX), a provider of information and analytics, down by 0.7% and Carnival (CUK), a cruise vacation company, down by 0.6%. CRH (CRH), building materials company, was 0.3% lower.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.